Sino Biopharmaceutical (PK) (SBHMY)
USOTC
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Assets | 18.38B | 20.94B | 49.78B | 37.51B | 47.21B | 60.54B | 64.06B | 63.6B |
Total Current Assets | 12.73B | 13.78B | 18.54B | 24.91B | 22.79B | 23.5B | 25.93B | 23.81B |
Cash and Equivalents | 3.77B | 4.19B | 6.68B | 11.91B | 11.26B | 10.57B | 6.41B | 9.45B |
Total Non-Current Assets | 10.68B | 12.61B | 37.55B | 20.56B | 22.42B | 37.73B | 37.94B | 38.17B |
Total Liabilities | 7.71B | 8.32B | 12.23B | 16.95B | 24.79B | 22.81B | 26.12B | 25.43B |
Total Current Liabilities | 5.66B | 5.69B | 9.67B | 8.12B | 10.94B | 15.35B | 20.15B | 22.61B |
Total Non-Current Liabilities | 3.73B | 4.85B | 3.07B | 16.76B | 26.91B | 13.15B | 10.23B | 4.2B |
Total Equity | 10.68B | 12.61B | 37.55B | 20.56B | 22.42B | 37.73B | 37.94B | 38.17B |
Common Equity | 170.03M | 170.03M | 278.85M | 278.45M | 415.9M | 415.44M | 414.9M | 414.62M |
Retained Earnings | 5.23B | 6.6B | 14.46B | 8.88B | 10.47B | 23.07B | 23.07B | 23.65B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.